| Identification | Back Directory | [Name]
3-Piperidinol, 2-[3-(4,5-dichloro-1H-benzimidazol-1-yl)propyl]-, (2R,3S)- | [CAS]
2241808-52-4 | [Synonyms]
Bersiporocin
3-Piperidinol, 2-[3-(4,5-dichloro-1H-benzimidazol-1-yl)propyl]-, (2R,3S)- | [Molecular Formula]
C15H19Cl2N3O | [MOL File]
2241808-52-4.mol | [Molecular Weight]
328.24 |
| Chemical Properties | Back Directory | [Boiling point ]
516.8±60.0 °C(Predicted) | [density ]
1.46±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
14.88±0.40(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Bersiporocin is a prolyl-tRNA synthetase inhibitor. Bersiporocin has an IC50 of ≤100 nM for phosphoribosylpyrophosphate synthetase (PRS). Bersiporocin can be used for the research of antifibrotic[1][2]. | [IC 50]
PRS: ≤100 nM (IC50) | [References]
[1] Bong-Yong Lee, et al. Heterocyclic compounds, preparation methods, pharmaceutical compositions, and use as pyrolyl-tRNA synthetase inhibitors.WO2018147626 A1
[2] WHO Drug Information, Vol. 35, No. 4, 2021. Geneva: World Health Organization; 2022. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|